Re: Neutropenic events in community practices reduced by first and subsequent cycle pegfilgrastim use.
Smith
Thomas J
TJ
Khatcheressian
James L
JL
D003153:Community Health Services; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D006801:Humans; D009503:Neutropenia / Q000517:prevention & control*; D011092:Polyethylene Glycols; D010818:Practice Patterns, Physicians'; D011994:Recombinant Proteins; D014481:United States
D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; C455861:pegfilgrastim; D011092:Polyethylene Glycols; D000069585:Filgrastim